NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance
10.3390/cancers10070228
Saved in:
Main Authors: | , , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
MDPI AG
2019
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/152462 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
id |
sg-nus-scholar.10635-152462 |
---|---|
record_format |
dspace |
spelling |
sg-nus-scholar.10635-1524622023-09-06T08:32:00Z NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance Monisha J. Roy N.K. Padmavathi G. Banik K. Bordoloi D. Khwairakpam A.D. Arfuso F. Chinnathambi A. Alahmadi T.A. Alharbi S.A. Sethi G. Kumar A.P. Kunnumakkara A.B. DEPT OF PHARMACOLOGY CANCER SCIENCE INSTITUTE OF SINGAPORE Drug resistance; mTOR pathway; Oral cancer; Secreted glycoprotein 10.3390/cancers10070228 Cancers 10 7 228 2019-03-20T03:46:15Z 2019-03-20T03:46:15Z 2018 Article Monisha J., Roy N.K., Padmavathi G., Banik K., Bordoloi D., Khwairakpam A.D., Arfuso F., Chinnathambi A., Alahmadi T.A., Alharbi S.A., Sethi G., Kumar A.P., Kunnumakkara A.B. (2018). NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance. Cancers 10 (7) : 228. ScholarBank@NUS Repository. https://doi.org/10.3390/cancers10070228 20726694 http://scholarbank.nus.edu.sg/handle/10635/152462 MDPI AG Scopus |
institution |
National University of Singapore |
building |
NUS Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NUS Library |
collection |
ScholarBank@NUS |
topic |
Drug resistance; mTOR pathway; Oral cancer; Secreted glycoprotein |
spellingShingle |
Drug resistance; mTOR pathway; Oral cancer; Secreted glycoprotein Monisha J. Roy N.K. Padmavathi G. Banik K. Bordoloi D. Khwairakpam A.D. Arfuso F. Chinnathambi A. Alahmadi T.A. Alharbi S.A. Sethi G. Kumar A.P. Kunnumakkara A.B. NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance |
description |
10.3390/cancers10070228 |
author2 |
DEPT OF PHARMACOLOGY |
author_facet |
DEPT OF PHARMACOLOGY Monisha J. Roy N.K. Padmavathi G. Banik K. Bordoloi D. Khwairakpam A.D. Arfuso F. Chinnathambi A. Alahmadi T.A. Alharbi S.A. Sethi G. Kumar A.P. Kunnumakkara A.B. |
format |
Article |
author |
Monisha J. Roy N.K. Padmavathi G. Banik K. Bordoloi D. Khwairakpam A.D. Arfuso F. Chinnathambi A. Alahmadi T.A. Alharbi S.A. Sethi G. Kumar A.P. Kunnumakkara A.B. |
author_sort |
Monisha J. |
title |
NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance |
title_short |
NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance |
title_full |
NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance |
title_fullStr |
NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance |
title_full_unstemmed |
NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance |
title_sort |
ngal is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance |
publisher |
MDPI AG |
publishDate |
2019 |
url |
http://scholarbank.nus.edu.sg/handle/10635/152462 |
_version_ |
1778169014461136896 |